Commission Implementing Regulation (EU) 2020/1425 of 8 October 2020 granting a Union authorisation for the biocidal product family ‘PeridoxRTU Product Family’ (Text with EEA relevance)
Commission Implementing Regulation (EU) 2020/1425of 8 October 2020granting a Union authorisation for the biocidal product family PeridoxRTU Product Family(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1., and in particular the first subparagraph of Article 44(5) thereof,Whereas:(1)On 26 September 2017, Contec Europe submitted an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 for authorisation of a biocidal product family named "PeridoxRTU Product Family" of product-type 2, as described in Annex V to that Regulation, providing written confirmation that the competent authority of Belgium had agreed to evaluate the application. The application was recorded under case number BC-HT057172-25 in the Register for Biocidal Products.(2)"PeridoxRTU Product Family" contains peracetic acid, as the active substance, which is included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012.(3)On 27 August 2019, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the conclusions of its evaluation to the European Chemicals Agency ("the Agency").(4)On 7 April 2020, the Agency submitted to the Commission an opinionECHA opinion of 5 March 2020 on the Union authorisation of "PeridoxRTU Product Family" (ECHA/BPC/247/2020), https://echa.europa.eu/bpc-opinions-on-union-authorisation., including the draft summary of the biocidal product characteristics ("SPC") of "PeridoxRTU Product Family" and the final assessment report on the biocidal product family in accordance with Article 44(3) of Regulation (EU) No 528/2012.(5)The opinion concludes that "PeridoxRTU Product Family" is a "biocidal product family" within the meaning of Article 3(1)(s) of Regulation (EU) No 528/2012, that it is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) and (6) of that Regulation.(6)On 27 April 2020, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.(7)The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for "PeridoxRTU Product Family".(8)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,HAS ADOPTED THIS REGULATION: